Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review
JE Megías-Vericat, D Martinez-Cuadron… - Expert Review of …, 2019 - Taylor & Francis
Introduction Induction chemotherapy based on anthracyclines and cytarabine (Ara-C)
combination remains the standard of care for acute myeloid leukemia (AML) patients who …
combination remains the standard of care for acute myeloid leukemia (AML) patients who …
Association analysis of TP53 rs1042522, MDM2 rs2279744, rs3730485, MDM4 rs4245739 variants and acute myeloid leukemia susceptibility, risk stratification scores …
This study aimed to explore the associations between the TP53 rs1042522 (TP53
Arg72Pro), MDM2 rs2279744 (MDM2 309T> G), rs3730485 (MDM2 del1518), MDM4 …
Arg72Pro), MDM2 rs2279744 (MDM2 309T> G), rs3730485 (MDM2 del1518), MDM4 …
[PDF][PDF] The Association between Single Nucleotide Polymorphisms rs1042522 and rs1642785 in the TP53 gene and Acute Myeloid leukemia in a sample of the …
HH Dawood, RK Mohammed - Baghdad Science Journal, 2024 - iasj.net
Acute myeloid leukemia (AML) represents the most prevalent type of acute leukemia in
adults and is responsible for approximately 80% of all cases. The tumor suppressor gene …
adults and is responsible for approximately 80% of all cases. The tumor suppressor gene …
Patients with secondary t-AML patients with TP53 Arg72Pro and SH2B3 W262R: A case report and review of the literature
Y Liu, T Yue - 2023 - researchsquare.com
Background: The incidence of therapy-related acute myeloblastic leukemia (t-AML) has
increased in recent years owing to advances in tumor treatment. Compared to de novo AML …
increased in recent years owing to advances in tumor treatment. Compared to de novo AML …
Precision medicine for TP53-mutated acute myeloid leukemia
MK Brattås, H Reikvam, THA Tvedt… - Expert Review of …, 2019 - Taylor & Francis
Introduction: TP53 mutations in acute myeloid leukemia (AML) are associated with poor
response to standard chemotherapy and high rates of relapse, even after allogeneic stem …
response to standard chemotherapy and high rates of relapse, even after allogeneic stem …
[HTML][HTML] The TP53 Pro72Arg SNP in de novo acute myeloid leukemia
E Schulz, H Sill - Haematologica, 2017 - ncbi.nlm.nih.gov
In a recent issue of Haematologica, Lucena-Araujo and co-workers report that the germline
variation rs1042522 in TP53, which encodes either proline (72Pro) or arginine (72Arg) …
variation rs1042522 in TP53, which encodes either proline (72Pro) or arginine (72Arg) …
[PDF][PDF] Zusammenhänge zwischen TP53-Mutationsstatus, genetischer Instabilität und Prognose bei MDS und sekundärer AML mit komplex aberrantem Karyotyp
RM Schaab - 2020 - ediss.uni-goettingen.de
Myelodysplastische Syndrome (MDS) bilden eine Gruppe von hämatologischen
Neoplasien, deren Diagnosestellung im Verlauf der letzten drei Dekaden zugenommen hat …
Neoplasien, deren Diagnosestellung im Verlauf der letzten drei Dekaden zugenommen hat …